Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial

Fig. 1

Summary of immunotherapeutic vaccine trials registered since 1999 to 2014. A, Total number of immunotherapeutic anti-cancer phase 2, phase 2 & 3 and phase 3 trials in dataset collected on 27th October 2014. B, Breakdown of the vaccine categories under investigation. Values above or below the arrow indicate the ratio of trials in Phase 3: Phase 2 for the vaccine category (# phase 3 trials/# phase 3 trials *100). C, Comparison of vaccine categories examined in trials completed between 1999–2013 and in 2014 onwards. D, Frequency of the most used adjuvants in vaccine trials completed between 1999–2013 and in 2014 onwards

Back to article page